MAS
WST icon

MPWM Advisory Solutions’s West Pharmaceutical WST Stock Holding History

MPWM Advisory Solutions’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$745K Hold
2,076
– – 0.34% 48
2026
Q1 		$520K Hold
2,076
– – 0.28% 58
2025
Q4 		$571K Hold
2,076
– – 0.32% 49
2025
Q3 		$545K Hold
2,076
– – 0.32% 46
2025
Q2 		$454K Buy
2,076
+2,074
+103,700% +$443K 0.29% 49
2025
Q1 		$448 Hold
2
– – ﹤0.01% 661
2024
Q4 		$655 Buy
+2
New +$629 ﹤0.01% 618

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

MPWM Advisory Solutions's WST Position: Q2 2026 in Review

MPWM Advisory Solutions held its West Pharmaceutical (WST) position steady in Q2 2026 at 2,076 shares worth $745K. The position accounts for 0.34% of the portfolio, ranked #48.

MPWM Advisory Solutions first reported a position in WST in Q4 2024 and has held it in 7 quarters since. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • MPWM Advisory Solutions held 2,076 shares of West Pharmaceutical worth $745K as of Q2 2026.
  • MPWM Advisory Solutions left its West Pharmaceutical share count unchanged in Q2 2026.
  • West Pharmaceutical made up 0.34% of MPWM Advisory Solutions's portfolio in Q2 2026, its #48 holding.
  • MPWM Advisory Solutions first reported a position in West Pharmaceutical in Q4 2024 and has held it in 7 quarters since.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on MPWM Advisory Solutions's 13F filing for Q2 2026, filed 13 Aug 2026.